Donley Matthew Maxwell

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Donley Matthew Maxwell's trades of Aurinia Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
10.07
Quantity 9,900 +inf%
Value US$99,739
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-11 2026-05-11
PrS Proposed sale
65,319
157.41
US$364,430 		65,319 157.41 US$364,430
2025-03-04 2025-03-04
S Sale
29,945 -47.3%
310.52
US$1,916,628 		29,945 -47.3% 310.52 US$1,916,628
2025-03-04 2025-03-03
S Sale
93,835 -27.4%
86.11
US$889,900 		93,835 -27.4% 86.11 US$889,900
2024-03-07 2024-03-06
S Sale
40,665 -6.5%
5.51
US$224,064 		40,665 -6.5% 5.51 US$224,064
2022-11-23 2022-11-21
PP Planned purchase
10,000 +55.8%
4.66
US$46,600 		10,000 +55.8% 4.66 US$46,600
2022-03-04 2022-03-02
S Sale
3,052 -15.8%
12.01
US$36,655 		3,052 -15.8% 12.01 US$36,655
2021-05-12 2021-05-11
B Purchase
9,900 +inf%
10.07
US$99,739 		9,900 +inf% 10.07 US$99,739